Pediatric Gastroenterology, Hepatology & Nutrition

  • 제25권4호
  • /
  • Pages.321-331
  • /
  • 2022
  • /
  • 2234-8646(pISSN)
  • /
  • 2234-8840(eISSN)
대한소아소화기영양학회 (The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition)
권호 표지
DOI QR코드

DOI QR Code

A New Perspective on the Quality of Life of Children with Glycogen Storage Diseases

  • Received : 2021.09.29
  • Accepted : 2022.06.02
  • Published : 2022.07.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

Abstract

Purpose: This study aimed to assess the quality of life (QoL) of children with glycogen storage disease (GSD) and their parents and to determine the impact of myopathies. Methods: A prospective case-control study was conducted at the Cairo University Children's Hospital and National Liver Institute, Menoufia University. A promising new style of questionnaire called the Stark Quality of Life Questionnaire was used to assess the quality of life. Results: Fifty-two children diagnosed with GSD (cases) and 55 age- and sex-matched healthy children (controls) were included. A statistically significant difference was found between cases and controls regarding food intake; mental behavior parameters such as mood, energy, and social contact; and physical behavior parameters such as running and tying shoelaces. Children with myopathies had significantly lower QoL scores in most of the parameters. Conclusion: GSDs alter children and their parents' mental and physical abilities. Lower QoL scores were detected in children with both skeletal myopathy and cardiomyopathy, but the difference was not statistically significant when compared with the children without myopathies.

Keywords

References

  1. Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. In: Goldman L, Schafer AI, eds. Goldman's Cecil medicine. 24th ed. Vol. 2. Philadelphia: Elsevier/Saunders, 2012:1354-7.
  2. Wolf CM, Arad M, Ahmad F, Sanbe A, Bernstein SA, Toka O, et al. Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations. Circulation 2008;117:144-54. https://doi.org/10.1161/CIRCULATIONAHA.107.726752
  3. Lu C, Qiu Z, Sun M, Wang W, Wei M, Zhang X. Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations. J Hum Genet 2016;61:641-5. https://doi.org/10.1038/jhg.2016.24
  4. Raben N, Sherman JB. Mutations in muscle phosphofructokinase gene. Hum Mutat 1995;6:1-6. https://doi.org/10.1002/humu.1380060102
  5. Fernandes J, Pikaar NA. Hyperlipemia in children with liver glycogen disease. Am J Clin Nutr 1969;22:617-27. https://doi.org/10.1093/ajcn/22.5.617
  6. Hoffmann GF, Smit PA, Schoser B. Glycogen storage diseases of all types. J Inherit Metab Dis 2015;38:389-90. https://doi.org/10.1007/s10545-015-9848-2
  7. Mogahed EA, Girgis MY, Sobhy R, Elhabashy H, Abdelaziz OM, El-Karaksy H. Skeletal and cardiac muscle involvement in children with glycogen storage disease type III. Eur J Pediatr 2015;174:1545-8. https://doi.org/10.1007/s00431-015-2546-0
  8. Myleus A, Petersen S, Carlsson A, Hammarroth S, Hogberg L, Ivarsson A. Health-related quality of life is not impaired in children with undetected as well as diagnosed celiac disease: a large population based cross-sectional study. BMC Public Health 2014;14:425. https://doi.org/10.1186/1471-2458-14-425
  9. Hardt J. A new questionnaire for measuring quality of life - the Stark QoL. Health Qual Life Outcomes 2015;13:174. https://doi.org/10.1186/s12955-015-0367-5
  10. Stark HP. Permission for using Stark QoL questionnaire [Internet]. Message to: Heba Safar.hebasafar97@ gmail.com. 2020 Jan 16. [3 paragraphs].
  11. Endo Y, Fateen E, El Shabrawy M, Aoyama Y, Ebara T, Murase T, et al. Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId. Clin Chem Lab Med 2009;47:1233-8.
  12. Apers S, Kovacs AH, Luyckx K, Thomet C, Budts W, Enomoto J, et al. Quality of life of adults with congenital heart disease in 15 countries: evaluating country-specific characteristics. J Am Coll Cardiol 2016;67:2237-45.
  13. Hardt J. A new questionnaire for measuring quality of life - the Stark QoL. Health Qual Life Outcomes 2015;13:174. https://doi.org/10.1186/s12955-015-0367-5
  14. Lloyd CE, Orchard TJ. Physical and psychological well-being in adults with Type 1 diabetes. Diabetes Res Clin Pract 1999;44:9-19. https://doi.org/10.1016/S0168-8227(99)00004-2
  15. Dunne TF, Geberhiwot T, Jones R. Acute psychosis in glycogen storage disease: a rare but severe complication. BMJ Case Rep 2019;12:e222307. https://doi.org/10.1136/bcr-2017-222307
  16. Preisler N, Pradel A, Husu E, Madsen KL, Becquemin MH, Mollet A, et al. Exercise intolerance in Glycogen Storage Disease Type III: weakness or energy deficiency? Mol Genet Metab 2013;109:14-20. https://doi.org/10.1016/j.ymgme.2013.02.008
  17. Storch E, Keeley M, Merlo L, Jacob M, Correia C, Weinstein D. Psychosocial functioning in youth with glycogen storage disease type I. J Pediatr Psychol 2008;33:728-38. https://doi.org/10.1093/jpepsy/jsn017
  18. Labrune P, Huguet P, Odievre M. Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients. Pediatr Cardiol 1991;12:161-3. https://doi.org/10.1007/BF02238523